Remote monitoring in dialysis: comparing RPM-APD, manual PD, and maintenance HD

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This multicenter, prospective observational study follows adults with ESRD who begin dialysis and are treated with RPM-assisted APD, manual PD, or maintenance HD. Researchers compare quality of life, social reintegration, clinical outcomes, and healthcare resource use across the three groups using propensity score matching to adjust for baseline differences. No interventions are assigned by the study; treatment choices are based on usual clinical practice and patient-physician decisions. Data are collected in real-world settings to understand how these modalities perform outside of randomized trials. The study aims to provide insights into effectiveness and resource needs across dialysis modalities in China.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Aged ≥ 18 years and \< 80 years.
* Diagnosed with ESRD and planned to initiate RPM-APD / manual PD / HD as maintenance dialysis within 3 months after signing the ICF.
* Able to continue long-term follow-up and treatment at the study site after enrollment.
* Voluntarily sign the ICF and are able to complete study visits and questionnaires as required by the Investigator or have a caregiver to assist in completing study-related procedures.

Exclusion Criteria:

* Diagnosed with acute kidney injury (AKI).
* Received dialysis therapy for more than 1 month.
* History of kidney transplantation.
* Presence of other severe diseases, such as malignancies with active or residual lesions despite treatment, systemic infections, decompensated liver cirrhosis, severe lactic acidosis, etc.
* Patients with HIV infection or syphilis infection.
* Presence of psychiatric disorders or inability to cooperate.
* Pregnant or breastfeeding women, as well as women of childbearing potential unwilling to use effective contraception during the study period.
* Currently participating in another interventional study or having participated in another interventional study within 1 month prior to enrollment.
* Any other condition that, in the opinion of the Investigator, makes the patient unsuitable for participation in the study.

Where it's running

• China-Japan Friendship Hospital
  Beijing, Beijing Municipality, China Recruiting
• Peking University First Hospital
  Beijing, Beijing Municipality, China Not yet recruiting
• Beijing Haidian Hospital
  Beijing, Beijing Municipality, China Not yet recruiting
• Peking University Third Hospital
  Beijing, Beijing Municipality, China Not yet recruiting
• The Second Affiliated Hospital of Chongqing Medical University
  Chongqing, Chongqing Municipality, China Not yet recruiting
• Guangdong Provincial Hospital of Traditional Chinese Medicine
  Guangzhou, Guangdong, China Not yet recruiting

Study contacts

• Study coordinator: Global CORP Clinical Trials Disclosure
• Email: Global.CORP.ClinicalTrialsDisclosure@vantive.com
• Phone: +1 2249484283

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Ticagrelor to See if Inflammation Drops in CKD Patients

  In adults with chronic kidney disease, this study tests whether ticagrelor can reduce inflammation compared with a placebo.

  Recruiting Phase 2 University of Arkansas · Little Rock, Arkansas · NCT07911124

• Omnisol-preserved kidneys before transplant (hypothermic machine perfusion)

  This study tests whether using Omnisol during hypothermic machine perfusion before kidney transplant can improve early graft function compared with standard preservation.

  Recruiting Vivalyx GmbH · Rotterdam · NCT07792317

• Extra Ultrafiltration to Remove Fluid in Hemodialysis Patients

  This trial tests whether adding extra ultrafiltration over 4 or 8 weeks helps people on in-center hemodialysis reduce excess body fluid and lower blood pressure.

  Recruiting University of Washington · Seattle, Washington · NCT07637110

• AdiaVita regenerative therapy for chronic kidney disease

  This trial tests whether AdiaVita (umbilical cord blood stem cells and exosomes plus glutathione) can improve kidney function in adults with stage 2–4 chronic kidney disease.

  Recruiting Phase 1 Adia Med of Winter Park LLC · Winter Park, Florida · NCT07572890

• Calciphylaxis in people with chronic kidney disease: causes, risks, and early signs

  This project will compare adults with chronic kidney disease who develop calciphylaxis to matched CKD patients who do not, collecting clinical data and biological samples to try to find risk factors and early signs.

  Recruiting Odense University Hospital · Odense · NCT07511283

• Multimedia education to improve fitness and activity for adults with chronic kidney disease.

  This project will test whether a multimedia video education program helps adults with mild-to-moderate chronic kidney disease increase physical activity and improve fitness over 12 weeks compared with standard education.

  Recruiting Fu Jen Catholic University Hospital · New Taipei City, Taishan District · NCT07493642

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.